Albemarle Corp (ALB)

Industry Specialty Chemicals


This stock can be held in an Investment ISA and an Investment Account
Sell

$178.54

Buy

$179.80

arrow-down$-0.38 (-0.21%)

Prices updated at 03 Apr 2026, 00:58 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Albemarle Corp is a developer, manufacturer and marketer of engineered specialty chemicals. It provides services to end markets including petroleum refining, consumer electronics, construction, automotive, lubricants and pharmaceuticals.

Income statement

20242025
5,378m5,143m
63m669m
-642m67m
-11.941.31
-1,179m-511m
-1,010m314m
Sales, General and administrative618m550m
Interest expenses166m208m
Provision for income taxes87m157m
Operating expenses705m601m
Income before taxes-1,764m-552m
Net income available to common shareholders-1,316m-677m
-11.2-5.76
Net interest income-166m-208m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-11.2-5.76
Free cash flow per share-12.00351.0296
Book value/share68.097265.93
Debt equity ratio0.4164490.441554

Balance sheet

20242025
Current assets3,842m4,008m
Current liabilities1,966m1,798m
Total capital13,080m12,653m
Total debt3,616m3,297m
Total equity9,962m9,533m
Total non current liabilities--
Loans3,118m3,119m
Total assets16,610m16,374m
Total liabilities--
Cash and cash equivalents1,192m1,618m
Common stock118m118m

Cash flow

20242025
Cash at beginning of period890m1,192m
Cash dividends paid-311m-357m
-984m692m
Investments (gains) losses-1,574m-146m
1,192m1,618m
Net income--
702m1,282m
-1,686m-590m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.